|
Oracain is a start-up Biotech company developing new oral pain medications based on known active compounds, reformulated to suit the present medical need in a range of indications.
The inventions originate from Hvidovre Hospital, Copenhagen, Denmark and are developed by Oracain in a virtual set-up, accessing top international expertise as needed.
Oracain was founded in early 2011 based on seed funding from Seed Capital and DTU Symbion Innovation.
|
Oracain ApS
CVR: 33 49 27 07
Diplomvej 381
DK-2800 Lyngby
Denmark
Contact:
Betina Thorball, CEO
bt@oracain.com
![]()
|
